Keefe, Bruyette & Woods cut its price target Wednesday on FXCM Inc(NYSE: FXCM) from $1.50 to $1 and maintained an Underperform rating.
FXCM is a gamble at best. IMO
10:22 AM EDT, 05/27/2015 (MT Newswires) -- EPIRUS Biopharmaceuticals ( EPRS)
shares were initiated by BTIG with buy and $15 price target.
$15 sounds too good. I'm looking for $8.
Remember these inspirational words......In The Long Run We're All Dead.
But first, there are years of suffering.
Stock shows Mildly Deteriorating Conditions. SCORE = -2
If you are long, hold current position. Do not initiate new position.
Thanks J- MAN for the list.
TCPC pays 8.98%, and I like it because it has been stable with average earnings.
RE: FSFR .....I'm conflicted, but will hold.
I think that this will be the 6th straight failed attempt to breakout to new highs and stocks should once again move lower.